| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/01/2000 | US6096312 Agent for suppressing a reduction of CD4+ lymphocytes |
| 08/01/2000 | US6096311 Methods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin G |
| 08/01/2000 | US6096310 Bactericides |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | CA2047717C Monoclonal antibodies for small moieties, methods therefor |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 07/29/2000 | CA2297137A1 New gene with down-regulated expression in metastatic human melanoma cells and a protein coded thereby, methods of production, and use thereof |
| 07/29/2000 | CA2258972A1 Apoptosis inhibitory protein, gene encoding the protein and cdna thereof |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043782A2 Removal of prions from blood, plasma and other liquids |
| 07/27/2000 | WO2000043774A2 Detection of small molecules by use of a piezoelectric sensor |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043524A1 Polypeptides derived from jnk3 |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043518A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043507A1 Method for producing antibody fragments |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043422A1 Methods for generating phosphorylation site-specific immunological reagents |
| 07/27/2000 | WO2000043421A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043420A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043040A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 07/27/2000 | WO2000043039A1 Vaccine-mediated treatment of neurological disorders |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043031A1 Tumor necrosis factor antagonists and their use in endometriosis |
| 07/27/2000 | WO2000043030A1 Method of suppressing ongoing acute allograff rejection |
| 07/27/2000 | WO2000023593A3 Molecular pathogenicide mediated plant disease resistance |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000021553A3 Method of regulating smn gene expression |
| 07/27/2000 | WO2000021550A3 Methods and compositions for treating neurodegenerative diseases |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000018909A3 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000005253A9 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999045116A9 Human homolog of a nuclear migration gene and its use |
| 07/27/2000 | CA2363846A1 Removal of prions from blood, plasma and other liquids |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361124A1 Vaccine-mediated treatment of neurological disorders |
| 07/27/2000 | CA2360667A1 Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| 07/27/2000 | CA2360658A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2358963A1 Cancer-associated proteins |
| 07/27/2000 | CA2358914A1 Polypeptides derived from jnk3 |
| 07/27/2000 | CA2358899A1 Polypeptide |
| 07/27/2000 | CA2358800A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | CA2354375A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/26/2000 | EP1022287A2 ADP-ribosylation factor-like proteins |
| 07/26/2000 | EP1022027A1 Tumor necrosis factor antagonists and their use in endometriosis |
| 07/26/2000 | EP1021728A1 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 07/26/2000 | EP1021725A1 Early detection of lysosomal storage disorders |
| 07/26/2000 | EP1021722A1 Improvements in or relating to screening for papilloma viruses |
| 07/26/2000 | EP1021721A1 Assays for tsh receptor autoantibodies |
| 07/26/2000 | EP1021564A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
| 07/26/2000 | EP1021545A2 Dengue virus antigens and treatment of dengue fever |
| 07/26/2000 | EP1021542A1 Apo-3 ligand |
| 07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021460A1 Laminins and uses thereof |
| 07/26/2000 | EP1021458A1 Helicobacter polypeptides and corresponding polynucleotide molecules |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP1007964A4 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/26/2000 | EP0786084A4 Method for screening compositions |
| 07/26/2000 | EP0769054B1 Immunomodulators |
| 07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |
| 07/26/2000 | CN1261286A CD154 blockade therapy for pancreatin islet tissue transplantation |
| 07/26/2000 | CN1261285A CD 154 blockade therapy for therapeutic protein inhibitor syndrome |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/26/2000 | CN1261104A Human oxido-reductase subunit and its coding sequence, preparing process and application |
| 07/26/2000 | CN1261103A Human targeting glycogen protein,and its coding sequence, preparing process and application |
| 07/25/2000 | US6093803 Method of producing aminoterminal propeptide of type 1 procollagen |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093796 Recombinant hK2 polypeptide |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093558 Applying to a substrate an adhesive comprising a nonproteinaceous polymer of monomeric units comprising an aromatic moiety having hydroxyl group(s); contacting a bioactive protein (such as cell) with substrate to immobilize |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093534 Monoclonal antibody specifically recognizing adeno-associated virus cap protein |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/25/2000 | US6093398 Treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction |
| 07/25/2000 | US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site, |
| 07/25/2000 | US6093324 Purification of immunoglobulins |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2094611C Hiv immunotherapeutics |
| 07/25/2000 | CA2015377C Autoantibodies which enhance the rate of a chemical reaction |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/20/2000 | WO2000042437A1 Methods for differentiating and monitoring parathyroid and bone status related diseases |